Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
Health-related quality of life in multiple sclerosis: psychometric analysis of inventoriesAriel Miller, Sara Dishon
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 10, 2006
Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment statusAriel Miller, Sara Dishon
International Journal of MS Care|January 24, 2014
The evolving role of the multiple sclerosis nurse: an international perspectiveTherese Burke, Sara Dishon, Lynn McEwan, et al.
Community Genetics|August 28, 2004
BRCA1/2 mutation carriers: living with susceptibilityLea Hagoel, Efrat Neter, Sara Dishon, et al.
Multiple Sclerosis International|November 19, 2011
Internet usage by patients with multiple sclerosis: implications to participatory medicine and personalized healthcareIzabella Lejbkowicz, Tamar Paperna, Nili Stein, et al.
American Journal of Obstetrics and Gynecology|August 5, 2008
Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutationOfer Lavie, Stephen B Gruber, Flavio Lejbkowicz, et al.
Annals of Neurology|June 24, 2008
Impact of exposure to war stress on exacerbations of multiple sclerosisDaniel Golan, Eli Somer, Sara Dishon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapseEli Somer, Daniel Golan, Sara Dishon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2009
BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi JewsLeon Raskin, Flavio Lejbkowicz, Ofra Barnett-Griness, et al.
Gastroenterology|March 23, 2011
High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutationBhramar Mukherjee, Gad Rennert, Jaeil Ahn, et al.
Pageof 2